Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2022)

First Author: Magavern EF
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ehjcvp/pvab063

PubMed Identifier: 34463331

Publication URI: http://europepmc.org/abstract/MED/34463331

Type: Journal Article/Review

Volume: 8

Parent Publication: European heart journal. Cardiovascular pharmacotherapy

Issue: 1